COVID-19
TOOLBOX
Filter
60
Featured
Language
Document type
Guidelines
27
Fact sheets
18
Studies & Reports
4
Manuals
3
Training Material
2
Infographics
2
App
1
Resource Platforms
1
Online Courses
1
Videos
1
Countries / Regions
Brazil
5
Germany
4
Latin America and the Carribbean
3
Middle East and North Africa
3
Syria
2
United Kingdom
2
Yemen
2
Mozambique
1
Guinea-Bissau
1
Russia
1
Angola
1
Authors & Publishers
World Health Organization WHO
25
Organisation Mondiale de la Santé OMS
3
Pan American Health Organisation PAHO
3
UNAIDS
3
UNICEF
3
World Health Organisation (WHO)
3
OPAS
2
Organización Mundial de la Salud OMS
2
Organização Mundial da Saúde (OMS)
2
Robert-Koch-Institut RKI
2
WHO
2
World Health Organization & United Nations Children's Fund (‎‎‎‎‎UNICEF)‎‎‎‎‎.
2
World Health Organization WHO, Regional Office of Africa
2
British Society for Immunlogy
1
British Society for Immunology
1
Clinical Care Options
1
GAVI The Vaccine Alliance
1
Goodman, T.
1
Infection Prevention and Control UHL, WHO Headquarters
1
Kim, A.
1
Mauder, S.
1
Mauder, S., K. Geffert
1
MEDBOX
1
Open WHO
1
OPS
1
Organisation Mondiale de la Santé, Bureau régional de l'OMS pour l'Afrique
1
Organización Mundial de Saude and OPAS
1
Organización Panamericana de la Salud
1
Organização Mundial da Saúde. Escritório Regional para a África
1
PAHO
1
S.R. Lewin and R. Sherer
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
Publication Years
Category
COVID-19
15
Guidelines
7
Vaccine-preventable Diseases
3
x MEDBOX Issue Brief & Annual Reports x
2
Immunization
2
Online Courses & Platforms
1
Medical Devices & Equipment
1
Policies
1
Waste Management
1
Toolboxes
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a... more
The backsliding of immunization coverage during the COVID-19 pandemic, combined with delayed catch-up efforts has resulted in a large and growing immunity gap. There is an urgent need to close this gap, and enable millions of missed children to be vaccinated. The Essential Immunization Recovery Plan... more
The introduction of vaccines for coronavirus disease 2019 (COVID-19) added another measure to the existing set of recommended preventive measures (wearing a mask in public, keeping a distance from other people and regular handwashing). The roll-out of the vaccines, however, raised concerns that vac... more
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations. It covers the following items: Global Reports Immunization Agenda 2030 and Regional reports Monkeypox RSV COVID-19 vacci... more
11 august 2022, updated version
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-... more
6 June 2022 These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. Th... more
This drill package is part of a broader COVID-19 simulation exercise package, including vaccine tabletop exercises(TTX). For exercises to be most effective, it is recommended they should be part of a comprehensive programme made up of progressively complex exercises, each exercise ... more
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp... more
5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and br... more
This course introduces participants to the foundations of vaccine pharmacovigilance. The aim of this course is to provide healthcare professionals whose work involve vaccine safety issues, with essential knowledge about vaccines and their safety aspects. These professionals can include nurses, midwi... more
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
11 May 2022 What are WHO's recommendations for COVID-19 vaccines and children? And what does the evidence say so far about the safety of these vaccines in children? And if you live in a country where this vaccination is not available for your kids, how can you keep them safe? WHO’s Dr Soumya Swa... more
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. fir... more
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
Frequently asked questions on COVID-19 vaccination. Version 6, 12 February 2022
WHO lists 9th COVID-19 vaccine for emergency use to expand vaccination access in low-income countries, 17 December 2021
Overview 16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Orientations provisoires 19 juillet 2021